XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (31,253) $ (18,586)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 2,402 1,130
Stock-based compensation 2,008 847
Changes in current assets and liabilities:    
Prepaid expenses and other assets 492 (2,219)
Prepaid rent (1,388) 0
Right-of-use assets and lease liabilities, net (60) 40
Accounts payable 1,232 1,593
Accrued expense and other liabilities (2,187) (325)
Deferred revenue (4,737) (3,137)
Net cash used in operating activities (33,491) (20,657)
Cash flows from investing activities:    
Purchases of property and equipment (2,424) (6,877)
Net cash used in investing activities (2,424) (6,877)
Cash flows from financing activities:    
Proceeds from issuance of convertible preferred stock, net of issuance costs 0 99,730
Proceeds from exercise of stock options 119 170
Payment of deferred offering costs 0 (960)
Net cash provided by financing activities 119 98,940
Net (decrease) increase in cash, cash equivalents and restricted cash (35,796) 71,406
Cash, cash equivalents, and restricted cash - beginning of period 166,436 35,386
Cash, cash equivalents, and restricted cash - end of period 130,640 106,792
Summary of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:    
Cash and cash equivalents 125,603 106,197
Restricted cash 5,037 595
Total cash, cash equivalents, and restricted cash 130,640 106,792
Supplemental cash flow information:    
Purchase of property and equipment in accounts payable and accrued liabilities 213 379
Deferred offering costs included in accrued expenses $ 0 $ 1,580